Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Gynecomastia × bicalutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 55 Breast Neoplasms 7 Bulbo-Spinal Atrophy, X-Linked 4 Neoplasms 3 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Salivary Gland Neoplasms 2 Stage I Prostate Adenocarcinoma 1 Recurrence 1 Paget Disease, Extramammary 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Lower Urinary Tract Symptoms 1 Gynecomastia 1 Fallopian Tube Neoplasms 1 Erectile Dysfunction 1 Carcinoma, Transitional Cell 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Adenocarcinoma 1

Interventions

bicalutamide 1 Tamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637871 2011-01-24

Casodex - Nolvadex Combination

AstraZeneca

Phase 2 Completed

Gynecomastia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡